中国药品标准
中國藥品標準
중국약품표준
DRUG STANDARDS OF CHINA
2014年
6期
413-416
,共4页
黄青%张婷%陆益红%史清水%张玫
黃青%張婷%陸益紅%史清水%張玫
황청%장정%륙익홍%사청수%장매
三氯叔丁醇%缩宫素注射液%高效液相色谱法%抑菌剂%含量测定
三氯叔丁醇%縮宮素註射液%高效液相色譜法%抑菌劑%含量測定
삼록숙정순%축궁소주사액%고효액상색보법%억균제%함량측정
chlorobutanol%Oxytocin Injection%HPLC%antibacterial agents%determination
目的:针对缩宫素注射液现行标准中未对抑菌剂三氯叔丁醇进行控制的情况,建立缩宫素注射液中三氯叔丁醇的HPLC测定法,并对不同企业生产的401批缩宫素注射液样品进行测定。方法:采用Waters XBridge-C18色谱柱(4.6 mm ×250 mm,5μm),以0.1 mol· L-1磷酸盐缓冲液作为流动相A,以水-乙腈(1∶1)作为流动相B,梯度洗脱,柱温40℃,流量为1.0 mL · min-1,检测波长为220 nm。结果:在选定的色谱条件下,三氯叔丁醇主峰和缩宫素主峰、杂质峰分离良好;三氯叔丁醇在浓度15.62~2000μg· mL-1范围内峰面积与浓度呈良好线性关系,r=1.0000;平均回收率98.6%(n=9)。401批缩宫素注射液中,三氯叔丁醇含量为0~1.78 mg· mL-1,不同企业间差异显著,且与处方量有一定差异。结论:该法专属性强,灵敏、准确,可作为缩宫素注射液中三氯叔丁醇的质量控制方法。市售制剂中的三氯叔丁醇含量在企业之间、企业内批间差异较大,且与处方标示量对应性较差。因此,有必要在缩宫素注射液中,增加三氯叔丁醇含量的检测项,以监控该品种中抑菌剂含量,促进企业稳定生产工艺,确保产品质量稳定、安全、有效。
目的:針對縮宮素註射液現行標準中未對抑菌劑三氯叔丁醇進行控製的情況,建立縮宮素註射液中三氯叔丁醇的HPLC測定法,併對不同企業生產的401批縮宮素註射液樣品進行測定。方法:採用Waters XBridge-C18色譜柱(4.6 mm ×250 mm,5μm),以0.1 mol· L-1燐痠鹽緩遲液作為流動相A,以水-乙腈(1∶1)作為流動相B,梯度洗脫,柱溫40℃,流量為1.0 mL · min-1,檢測波長為220 nm。結果:在選定的色譜條件下,三氯叔丁醇主峰和縮宮素主峰、雜質峰分離良好;三氯叔丁醇在濃度15.62~2000μg· mL-1範圍內峰麵積與濃度呈良好線性關繫,r=1.0000;平均迴收率98.6%(n=9)。401批縮宮素註射液中,三氯叔丁醇含量為0~1.78 mg· mL-1,不同企業間差異顯著,且與處方量有一定差異。結論:該法專屬性彊,靈敏、準確,可作為縮宮素註射液中三氯叔丁醇的質量控製方法。市售製劑中的三氯叔丁醇含量在企業之間、企業內批間差異較大,且與處方標示量對應性較差。因此,有必要在縮宮素註射液中,增加三氯叔丁醇含量的檢測項,以鑑控該品種中抑菌劑含量,促進企業穩定生產工藝,確保產品質量穩定、安全、有效。
목적:침대축궁소주사액현행표준중미대억균제삼록숙정순진행공제적정황,건립축궁소주사액중삼록숙정순적HPLC측정법,병대불동기업생산적401비축궁소주사액양품진행측정。방법:채용Waters XBridge-C18색보주(4.6 mm ×250 mm,5μm),이0.1 mol· L-1린산염완충액작위류동상A,이수-을정(1∶1)작위류동상B,제도세탈,주온40℃,류량위1.0 mL · min-1,검측파장위220 nm。결과:재선정적색보조건하,삼록숙정순주봉화축궁소주봉、잡질봉분리량호;삼록숙정순재농도15.62~2000μg· mL-1범위내봉면적여농도정량호선성관계,r=1.0000;평균회수솔98.6%(n=9)。401비축궁소주사액중,삼록숙정순함량위0~1.78 mg· mL-1,불동기업간차이현저,차여처방량유일정차이。결론:해법전속성강,령민、준학,가작위축궁소주사액중삼록숙정순적질량공제방법。시수제제중적삼록숙정순함량재기업지간、기업내비간차이교대,차여처방표시량대응성교차。인차,유필요재축궁소주사액중,증가삼록숙정순함량적검측항,이감공해품충중억균제함량,촉진기업은정생산공예,학보산품질량은정、안전、유효。
Objective:To develop a gradient liquid chromatographic method for the determination of chlorobutanol in Oxytocin Injection and analyze 401 batches of Oxytocin Injection samples.Methods: A Waters XBridge-C18 column (4.6 mm ×250 mm, 5 μm) was used for the gradient elution.The mobile phases consisted of 0.1 mol· L-1 phosphate buffer as A and water-acetonitrile (1∶1) as B, the flow rate was 1.0 mL· min-1 ,UV detection was performed at 220 nm and the column temperature was set to 40℃.Results:Chlo-robutanol was well separated from oxytocin and its related substances by the established method.The calibration curve was linear be-tween peak area and oxytocin concentration at the range of 15.62-2000μg· mL-1 with r=1.0000, the average recovery ( n=9) was 98.6%.In 401 batchs of Oxytocin Injection samples, the contents of chlorobutanol were 0-1.78 mg· mL-1.Conclusion:The meth-od is proved to be specific, sensitive and accurately and could be used to control the quality of Oxytocin Injection.Furthermore the re-search results showed the contents of chlorobutanol had significant differences between manufacturers and batches, prescription and the actual content, it is necessary to improve the quality standards of Oxytocin Injection to control the content of chlorobutanol, ensuring the stability, safety and effectivity of the products.